New Index Rates Drug Companies in Fight Against ‘Superbugs’

Glaxo and Johnson & Johnson top a new measure of how drugmakers do against antibiotic-resistant bacteria, which are becoming a global emergency. DONALD G. McNEIL Jr. http://ift.tt/2Dxuy4Y http://ift.tt/2Dy5Wcd The New York Times Health Antibiotics, Drugs (Pharmaceuticals) January 23, 2018 at 12:00AM